.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Mallinckrodt
Novartis
Federal Trade Commission
Julphar
US Department of Justice
Argus Health
US Army
Chubb
McKesson

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203729

« Back to Dashboard
NDA 203729 describes QUININE SULFATE, which is a drug marketed by Lupin Ltd, Amneal Pharms, Teva Pharms, Riconpharma Llc, and Mylan Pharms Inc, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the QUININE SULFATE profile page.

The generic ingredient in QUININE SULFATE is quinine sulfate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

Summary for NDA: 203729

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 203729

Suppliers and Packaging for NDA: 203729

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL 203729 ANDA Amneal Pharmaceuticals of New York, LLC 65162-811 65162-811-03 30 CAPSULE in 1 BOTTLE (65162-811-03)
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL 203729 ANDA Amneal Pharmaceuticals of New York, LLC 65162-811 65162-811-09 90 CAPSULE in 1 BOTTLE (65162-811-09)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength324MG
Approval Date:Jul 15, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Merck
Fuji
Cantor Fitzgerald
Chubb
Argus Health
Novartis
Fish and Richardson
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot